Since the outbreak of COVID-19 in December 2019, which was caused SARS-CoV-2, COVID-19-associated ALI/ARDS has been widely discussed, and the role of NLRP3 inflammasome in its progressing has received great attention. Here, NLRP3 is linked to acute respiratory distress syndrome.